Minoxidil and finasteride are the two most extensively studied medications for androgenetic alopecia. Both have decades of clinical data behind them, but they work through different mechanisms and address different aspects of pattern hair loss. Understanding how they differ, and when they are typically used together, helps clarify why physicians often consider both during treatment planning.
This page provides a medically neutral comparison of the two medications.
What each medication is
Minoxidil
Minoxidil was originally developed as an oral antihypertensive and was observed to cause hair growth as a side effect, leading to its repurposing for hair loss. It is now available in:
- Topical solutions and foams at concentrations of 2% and 5%, applied directly to the scalp
- Low-dose oral tablets, prescribed off-label at doses generally between 1.25 mg and 5 mg per day
The topical form is the most widely used and is FDA-approved for androgenetic alopecia. Low-dose oral minoxidil has gained traction in recent years based on emerging clinical data suggesting comparable or superior outcomes versus topical use in some patients.
Finasteride
Finasteride is an oral medication that inhibits the enzyme Type 2 5-alpha reductase, reducing the conversion of testosterone to DHT. At the standard 1 mg daily dose used for hair loss, it lowers scalp DHT by approximately 60%. A topical finasteride formulation has also emerged in recent years, designed to deliver the medication to the scalp with reduced systemic exposure, although evidence for the topical form is less established than for the oral form.
Finasteride is approved for androgenetic alopecia in men. It is not approved for use in women, particularly those of reproductive age, due to risk of fetal harm.
How each medication works
Minoxidil's mechanism
Minoxidil's exact mechanism is not fully understood, but the drug is known to:
- Open potassium channels in cells around the hair follicle, promoting vasodilation
- Extend the anagen (active growth) phase of the hair cycle
- Increase hair shaft diameter and pigmentation over time
It does not directly affect DHT or address the hormonal driver of androgenetic alopecia. Instead, it supports the activity of follicles, including those that are partially miniaturized but still functional.
Finasteride's mechanism
Finasteride works upstream of follicle activity by reducing DHT availability. By inhibiting Type 2 5-alpha reductase, it lowers the local concentration of DHT in scalp tissue. This slows or prevents follicle miniaturization, which is the underlying process driving pattern hair loss.
The two medications therefore address complementary parts of the same problem: finasteride targets the hormonal cause, while minoxidil supports the follicle's growth response.
Side-by-side comparison
| Feature | Minoxidil | Finasteride |
|---|---|---|
| Mechanism | Extends anagen phase, supports follicle activity | Reduces DHT by inhibiting 5-alpha reductase |
| Forms available | Topical 2-5%, oral low-dose | Oral 1 mg, topical formulations |
| FDA approval status (men) | Approved (topical) | Approved |
| FDA approval status (women) | Approved (topical) | Not approved |
| Time to visible response | 3 to 6 months typically | 3 to 6 months typically |
| Common shedding phase | Yes, weeks 2-8 | Possible but less common |
| Maintenance required | Yes, ongoing | Yes, ongoing |
| Effect on DHT | None | Reduces by approximately 60% |
| Used in combination with the other | Commonly | Commonly |
This comparison is for educational purposes. Treatment selection should be based on individualised medical assessment.
Topical versus oral considerations
For minoxidil, the choice between topical and oral formulations depends on:
- Convenience: oral once daily versus topical twice daily
- Scalp tolerance: topical may cause irritation in some users
- Systemic considerations: oral can produce systemic effects such as fluid retention or unwanted body hair growth and requires medical screening
For finasteride, the choice between oral and topical involves:
- Systemic exposure: topical delivers less systemically, which may reduce risk of certain side effects
- Evidence base: oral has more extensive clinical data; topical is supported by smaller trials
- Practical factors: pill versus daily topical application
A physician can advise on which formulation is more appropriate based on a person's medical history and treatment goals.
Combination therapy
Clinical evidence supports the use of minoxidil and finasteride together for men with progressing androgenetic alopecia, when both are medically appropriate. Studies suggest combination therapy produces:
- Greater stabilization of hair loss than either alone
- More visible thickening
- Higher rates of patient-reported improvement
The mechanistic rationale is straightforward. Finasteride reduces the hormonal pressure on follicles, while minoxidil supports the activity of follicles whose growth phase has been compromised. The two are not redundant.
For this reason, physicians often consider initiating both medications together when starting treatment for established pattern hair loss, particularly in men presenting at moderate stages of the Norwood scale.
Side effects and tolerance
Minoxidil
The most common side effects include:
- Scalp irritation, dryness, or itching (with topical use)
- Initial shedding during weeks 2-8 of treatment, which is typically transient
- Lightheadedness, palpitations, or fluid retention with oral use, which require medical screening before initiation
- Hypertrichosis (unwanted body hair growth) with oral use in some individuals
Most side effects are mild and self-limited. Serious adverse events with oral minoxidil are uncommon at the low doses used for hair loss but warrant ongoing physician oversight.
Finasteride
Reported side effects include:
- Sexual side effects (reduced libido, erectile changes, ejaculatory changes), reported in clinical trials at rates of approximately 2-4% above placebo
- Mood changes in a small subset of users
- Breast tenderness or enlargement, uncommon
- Resolution of side effects typically follows discontinuation, although a small number of post-finasteride syndrome reports exist and remain a subject of clinical discussion
A physician's role includes screening for risk factors before prescribing and monitoring for adverse effects during treatment.
Who is each medication appropriate for
Minoxidil
Minoxidil may be appropriate for:
- Men and women with androgenetic alopecia
- Those experiencing diffuse thinning or early-stage pattern loss
- Those who prefer to start with a non-hormonal approach
- Those for whom 5-alpha reductase inhibitors are contraindicated
Finasteride
Finasteride may be appropriate for:
- Men with progressing androgenetic alopecia, when medically suitable
- Those for whom DHT suppression is the priority intervention
- Those who can commit to ongoing oral therapy
It is not appropriate for women of reproductive age and is contraindicated in pregnancy due to fetal risk.
Combination
Combination minoxidil and finasteride may be appropriate for:
- Men with moderate to advanced pattern hair loss
- Those seeking the strongest evidence-based monotherapy alternative
- Those whose response to either agent alone has been incomplete
In all cases, treatment selection requires medical assessment and ongoing physician oversight.
What this comparison does not replace
Online comparisons cannot substitute for individualised medical evaluation. Factors such as overall health, concurrent medications, family history, reproductive plans, and personal tolerance for side effects all influence which medication or combination is suitable. A physician's assessment is the appropriate venue for those decisions.
How Curekey provides access
Curekey is a HIPAA-compliant telehealth platform where licensed U.S. physicians review each case and determine whether medication is appropriate. Whether the treatment plan involves minoxidil, finasteride, or a combination, prescriptions are issued only when medically appropriate and are fulfilled by licensed pharmacies. The full process is described on the how it works page.
Considering an assessment
If you are weighing treatment options for pattern hair loss, a structured medical assessment can clarify which medication or combination is appropriate for your case. Curekey's process includes history review, photo evaluation, physician consultation, and follow-up care. Results vary, and treatment is selected based on clinical suitability rather than presumed effectiveness in isolation.
